Related references
Note: Only part of the references are listed.Chemoprotective Antimalarial Activity of P218 against Plasmodium falciparum: A Randomized, Placebo-Controlled Volunteer Infection Study
Mohamed Farouk Chughlay et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2021)
Transgenic pyrimethamine-resistant plasmodium falciparum reveals transmission-blocking potency of P218, a novel antifolate candidate drug
Navaporn Posayapisit et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2021)
First-in-human clinical trial to assess the safety, tolerability and pharmacokinetics of P218, a novel candidate for malaria chemoprotection
M. Farouk Chughlay et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2020)
Molecular characterization of Plasmodium falciparum antifolate resistance markers in Thailand between 2008 and 2016
Rungniran Sugaram et al.
MALARIA JOURNAL (2020)
When Is a Plasmodium-Infected Mosquito an Infectious Mosquito?
Wouter Graumans et al.
TRENDS IN PARASITOLOGY (2020)
T cell-mediated immunity to malaria
Samarchith P. Kurup et al.
NATURE REVIEWS IMMUNOLOGY (2019)
Checks and balances? DNA replication and the cell cycle in Plasmodium
Holly Matthews et al.
PARASITES & VECTORS (2018)
A comprehensive model for assessment of liver stage therapies targeting Plasmodium vivax and Plasmodium falciparum
Alison Roth et al.
NATURE COMMUNICATIONS (2018)
Unraveling the Plasmodium vivax sporozoite transcriptional journey from mosquito vector to human host
Alison Roth et al.
SCIENTIFIC REPORTS (2018)
Grammomys surdaster, the Natural Host for Plasmodium berghei Parasites, as a Model to Study Whole-Organism Vaccines against Malaria
Solomon Conteh et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2017)
Within-Host Selection of Drug Resistance in a Mouse Model of Repeated Incomplete Malaria Treatment: Comparison between Atovaquone and Pyrimethamine
Suci Nuralitha et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Malaria: Biology and Disease
Alan F. Cowman et al.
CELL (2016)
High-Throughput Luciferase-Based Assay for the Discovery of Therapeutics That Prevent Malaria
Justine Swann et al.
ACS INFECTIOUS DISEASES (2016)
Human iPSC-Derived Hepatocyte-like Cells Support Plasmodium Liver-Stage Infection In Vitro
Shengyong Ng et al.
STEM CELL REPORTS (2015)
Malarial dihydrofolate reductase as a paradigm for drug development against a resistance-compromised target
Yongyuth Yuthavong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Chronicle of a death foretold: Plasmodium liver stage parasites decide on the fate of the host cell
Stefanie Graewe et al.
FEMS MICROBIOLOGY REVIEWS (2012)
Induction of Antimalaria Immunity by Pyrimethamine Prophylaxis during Exposure to Sporozoites Is Curtailed by Parasite Resistance
Johannes Friesen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Quadruple mutations in dihydrofolate reductase of Plasmodium falciparum isolates from Car Nicobar Island, India
A Ahmed et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Sulfadoxine-pyrimethamine resistance in the rodent malaria parasite Plasmodium chabaudi
K Hayton et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Share Paper
